These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7767482)

  • 1. [Quality of platelet products: current methods of in vitro assessment].
    Masse M
    Transfus Clin Biol; 1995; 2(2):79-84. PubMed ID: 7767482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, storage and quality control of platelet concentrates.
    Tynngård N
    Transfus Apher Sci; 2009 Oct; 41(2):97-104. PubMed ID: 19699153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.
    Mathai J; Resmi KR; Sulochana PV; Sathyabhama S; Baby Saritha G; Krishnan LK
    Platelets; 2006 Sep; 17(6):393-6. PubMed ID: 16973500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.
    Bertolini F; Murphy S
    Transfusion; 1996 Feb; 36(2):128-32. PubMed ID: 8614962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
    Wang X; Fan Y; Shi R; Li J; Zhao S
    Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
    van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
    Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation.
    Javela K; Eronen J; Sarna S; Kekomäki R
    Transfusion; 2005 Sep; 45(9):1504-11. PubMed ID: 16131384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.
    Diedrich B; Sandgren P; Jansson B; Gulliksson H; Svensson L; Shanwell A
    Vox Sang; 2008 Feb; 94(2):96-102. PubMed ID: 18034788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buffy coat platelets stored in apyrase, aprotinin, and ascorbic acid in a suspended bag: combined strategies for reducing platelet activation during storage.
    Mrowiec ZR; Oleksowicz L; Zuckerman D; De Leon-Fernandez M; Khorshidi M; Dutcher JP; Puszkin EG
    Transfusion; 1996 Jan; 36(1):5-10. PubMed ID: 8607153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags.
    Cardigan R; Sutherland J; Garwood M; Bashir S; Turner C; Smith K; Hancock V; Wiltshire M; Pergande C; Williamson LM
    Vox Sang; 2008 Feb; 94(2):103-12. PubMed ID: 18034786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple morphological score for the quality control of platelet concentrates.
    Mitrović S; Mitrović D; Dragojlović Z; Todorović V; Cuk G; Nedeljković N; Gligorović V
    Haematologia (Budap); 1997; 28(4):239-46. PubMed ID: 9408768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.
    Feys HB; Devloo R; Sabot B; De Pourcq K; Coene J; Compernolle V
    Vox Sang; 2017 Nov; 112(8):751-758. PubMed ID: 28960339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts about current conditions for the preparation and storage of platelets.
    Moroff G; Holme S
    Transfus Med Rev; 1991 Jan; 5(1):48-59. PubMed ID: 1802276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
    Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
    Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the interruption of agitation on platelet quality during storage for transfusion.
    Hunter S; Nixon J; Murphy S
    Transfusion; 2001 Jun; 41(6):809-14. PubMed ID: 11399825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.
    Bertolini F; Murphy S
    Transfusion; 1994 Sep; 34(9):796-801. PubMed ID: 8091470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Storage and quality assessment of platelets.
    Holme S
    Vox Sang; 1998; 74 Suppl 2():207-16. PubMed ID: 9704447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.